^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Senl-h19

    i
    Other names: Senl-h19
    Associations

    News

    Trials
    Company:
    SenlangBio
    Drug class:
    CD19-targeted CAR-T immunotherapy
    Related drugs:
    Associations

    News

    Trials
    3years
    Senl-h19 CAR-T Cell Injection in the Treatment of Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (clinicaltrials.gov)
    P=N/A, N=15, Recruiting, Hebei Senlang Biotechnology Inc., Ltd.
    Clinical • New trial • CAR T-Cell Therapy
    |
    CD19 (CD19 Molecule) • IFNG (Interferon, gamma) • IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • IL10 (Interleukin 10) • CD7 (CD7 Molecule)
    |
    CD19 positive
    |
    Senl-h19